The Cardiovascular Stents Market is expanding due to the rising prevalence of cardiovascular diseases such as coronary artery disease, peripheral artery disease, and arterial blockages. In 2025, the market was valued at USD 14.73 Billion and is expected to grow at a CAGR of 4.80% during 2026–2035, reaching USD 23.54 Billion. Increasing demand for minimally invasive procedures, technological advancements in stent design, and a growing geriatric population are major factors driving market growth globally.

Cardiovascular Stents Market Size, Share, and Trend

The Cardiovascular Stents Market size is increasing as hospitals, specialty clinics, and catheterization labs adopt innovative stent technologies. Market trends indicate a shift toward drug-eluting stents (DES) and bioresorbable stents, which reduce restenosis and improve patient outcomes. North America currently dominates the market share, while Asia Pacific is emerging as a high-growth region due to rising healthcare expenditure and expanding cardiac care infrastructure.

Market Breakup by Product Type and Type

Product Type: Coronary stenting and peripheral stenting for arterial and venous diseases.

Type: Drug-eluting stents (DES), bioresorbable stents, bare metal stents, dual therapy stents, and others.

Market Breakup by Material and Disease Indication

Material: Stainless steel, cobalt chromium, nitinol, and polymers.

Disease Indication: Venous diseases and arterial diseases, with increasing prevalence of arterial disorders driving stent adoption.

Market Breakup by End User and Region

End Users: Hospitals, ambulatory surgery centers, specialty clinics, and catheterization labs.

Regions: North America, Europe, Asia Pacific, Latin America, Middle East & Africa. North America holds the largest market share due to advanced cardiac care, while Asia Pacific is poised for rapid growth.

Request sample report Explore

Key Companies in the Cardiovascular Stents Market

Major players include Cordis US Corp, BIOTRONIK SE & Co KG, MicroPort Scientific Corporation, Abbott Laboratories, Boston Scientific Corporation, Medtronic Plc, Cardinal Health Inc., Cook Medical Inc., C. R. Bard, Inc. (BD), Terumo Corporation, and B. Braun Melsungen AG. These companies focus on product innovation, clinical trials, and global market expansion.